monday.com
MNDY
83.51
-0.78
-0.93%
monday.com
US · MNDY
#2395 by market cap
Listed 2021
83.51
-0.78
-0.93%
Live - 5344 symbols - heartbeat 193s ago
· 2026-10-08 08:27
Pre-market
83.82
+0.37%
After-hours
83.51
0.00%
Overnight
83.07
-0.53%
- Market cap
- 3.53B
- P/E (TTM)i
- 35.39
- P/Bi
- 5.71
- EPSi
- 2.24
- Div yieldi
- 0.00%
- 52W posi
- 17%
Reader sentiment
Are you bullish or bearish on MNDY?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.37, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 7 years
Latest year +26.75% YoY
Margins
- Gross margin
- 89.20%
- Operating margin
- -0.14%
- Net margin
- 9.64%
Key ratios & quality
- Altman Z-Scorei
- 3.37
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 78.09M | 161.12M | 308.15M | 519.03M | 729.70M | 972.00M | 1.23B |
| Gross profit | 66.11M | 138.64M | 269.14M | 452.50M | 649.05M | 868.30M | 1.10B |
| Selling & admin expenses | 133.99M | 245.69M | 321.58M | 477.47M | 531.14M | 675.63M | 779.85M |
| Research & development | 24.64M | 43.48M | 73.69M | 127.05M | 156.50M | 213.71M | 320.80M |
| Operating profit | -92.52M | -150.54M | -126.13M | -152.02M | -38.59M | -21.03M | -1.75M |
| Pretax profit | -90.93M | -150.01M | -126.96M | -129.46M | 3.33M | 34.47M | 59.32M |
| Tax | 683.00K | 2.19M | 2.33M | 7.41M | 5.20M | 2.09M | -59.43M |
| Net profit | -91.61M | -152.20M | -129.29M | -136.87M | -1.88M | 32.37M | 118.74M |
| Basic EPS | -2 | -4 | -5 | -3 | 0 | 1 | 2 |
| Diluted EPS | -2.36 | -3.92 | -4.53 | -2.99 | -0.04 | 0.62 | 2.24 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 282.25M | 299.01M | 316.86M | 333.88M | 351.27M | 364.62M |
| Gross profit | 253.45M | 267.84M | 281.07M | 296.55M | 313.14M | 321.96M |
| Selling & admin expenses | 174.26M | 192.35M | 203.99M | 209.24M | 201.37M | 202.76M |
| Research & development | 69.39M | 87.04M | 79.45M | 84.92M | 92.02M | 99.31M |
| Operating profit | 9.80M | -11.55M | -2.38M | 2.39M | 19.75M | 19.89M |
| Pretax profit | 27.44M | 2.55M | 13.38M | 15.94M | 30.13M | 5.42M |
| Tax | 18.00K | 978.00K | 332.00K | -60.75M | 2.10M | 1.96M |
| Net profit | 27.43M | 1.57M | 13.05M | 76.69M | 28.03M | 3.46M |
| Basic EPS | 1 | 0 | 0 | 1 | 1 | 0 |
| Diluted EPS | 0.52 | 0.03 | 0.25 | 1.45 | 0.57 | 0.08 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Total current assets | 181.31M | 147.62M | 913.49M | 923.85M | 1.17B | 1.53B | 1.79B |
| Cash & ST investments | 175.60M | 139.81M | 886.81M | 885.89M | 1.12B | 1.46B | 1.67B |
| Inventory | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 185.15M | 157.42M | 933.19M | 1.04B | 1.28B | 1.69B | 2.11B |
| Total current liabilities | 80.76M | 140.44M | 228.19M | 298.22M | 416.01M | 575.62M | 714.87M |
| Short-term debt | 13.11M | 21.10M | 84.00K | 19.08M | 18.20M | 29.01M | 25.82M |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 315,769,000.00 | 374,977,000.00 | 229,797,000.00 | 359,303,000.00 | 462,148,000.00 | 655,277,000.00 | 859,764,000.00 |
| Total equity | -130.62M | -217.56M | 703.40M | 679.74M | 813.51M | 1.03B | 1.25B |
| Retained earnings | -164.16M | -316.37M | -445.66M | -582.53M | -584.40M | -552.03M | -433.29M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.67B | 1.77B | 1.86B | 1.79B | 1.35B | 1.21B |
| Cash & ST investments | 1.59B | 1.65B | 1.74B | 1.67B | 1.21B | 1.07B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 1.85B | 1.96B | 2.06B | 2.11B | 1.69B | 1.62B |
| Total current liabilities | 649.17M | 672.91M | 697.10M | 714.87M | 782.38M | 789.87M |
| Short-term debt | 29.34M | 29.83M | 27.22M | 25.82M | 28.53M | 27.51M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 745,031,000.00 | 771,593,000.00 | 791,327,000.00 | 859,764,000.00 | 933,508,000.00 | 1,001,944,000.00 |
| Total equity | 1.10B | 1.19B | 1.27B | 1.25B | 758.69M | 617.98M |
| Retained earnings | -524.61M | -523.03M | -509.98M | -433.29M | -405.26M | -401.80M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -36.65M | -37.18M | 16.36M | 27.14M | 215.40M | 311.07M | 333.64M |
| Depreciation & amortization | 579.00K | 1.89M | 2.75M | 8.57M | 9.02M | 11.86M | 13.81M |
| Free cash flow | -38.42M | -42.66M | 2.60M | 8.14M | 204.95M | 295.83M | 309.90M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | 735.86M | -- | 0 | 0 | -135.03M |
| Ending cash balance | 172.00M | 131.81M | 886.81M | 885.89M | 1.12B | 1.41B | 1.50B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 111.97M | 66.84M | 95.14M | 59.69M | 104.69M | 55.35M |
| Depreciation & amortization | 3.25M | 3.38M | 3.50M | 3.68M | 3.85M | 3.97M |
| Free cash flow | 107.50M | 60.03M | 90.22M | 52.15M | 101.76M | 50.46M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | -- | -- | -552.61M | -182.36M |
| Ending cash balance | 1.53B | 1.59B | 1.53B | 1.50B | 997.14M | 853.40M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -53.23 | -19.79 | -0.25 | 3.51 | 10.43 |
| ROA %i | -49.48 | -88.86 | -23.71 | -13.88 | -0.16 | 2.19 | 6.26 |
| ROIC %i | -- | -- | -51.14 | -19.83 | -4.05 | -2.46 | 5.51 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -11.87 |
| EBIT margin %i | -115.75 | -92.69 | -41.07 | -24.93 | 0.46 | 3.55 | -0.14 |
| FCF / sales %i | -- | -- | 0.84 | 1.57 | 28.09 | 30.44 | 25.15 |
| Current ratioi | 2.25 | 1.05 | 4.00 | 3.10 | 2.82 | 2.66 | 2.50 |
| Quick ratioi | 2.22 | 1.02 | 3.92 | 3.03 | 2.75 | 2.60 | 2.38 |
| Debt / assetsi | 7.08 | 13.41 | 0.01 | 7.48 | 4.79 | 6.29 | 8.01 |
| LT debt / equityi | -- | -- | -- | 8.63 | 5.28 | 7.48 | 11.46 |
| Interest coveragei | -166.45 | -222.56 | -312.49 | -2,087.08 | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | 88.02 | 65.45 | 46.66 | 33.39 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | 384.76 | 236.45 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 5.39 | 3.80 | 5.81 | 10.43 | 12.83 | 13.39 |
| ROA %i | 3.26 | 2.33 | 3.57 | 6.26 | 6.75 | 6.77 |
| ROIC %i | -1.05 | -2.01 | 0.01 | 5.51 | 7.84 | 7.98 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 4.75 | 3.27 | 5.23 | -0.14 | 0.63 | 2.90 |
| FCF / sales %i | 30.22 | 29.33 | 28.34 | 25.15 | 23.38 | 21.56 |
| Current ratioi | 2.57 | 2.64 | 2.67 | 2.50 | 1.72 | 1.53 |
| Quick ratioi | 2.49 | 2.51 | 2.54 | 2.38 | 1.59 | 1.40 |
| Debt / assetsi | 6.64 | 6.43 | 5.79 | 8.01 | 10.49 | 14.66 |
| LT debt / equityi | 8.46 | 8.08 | 7.26 | 11.46 | 19.65 | 33.98 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 08:27:04 · For reference only, not investment advice and not tailored to your situation.